Medi Plus (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.17 M
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 49.12 Cr
- Satisfied Charges ₹ 64.10 Cr
- Revenue Growth 24.06%
- Profit Growth 21.00%
- Ebitda -11.68%
- Net Worth 10.41%
- Total Assets 18.11%
About Medi Plus (India)
Medi Plus (India) Limited (MPIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 12 December 1994 and has a history of 30 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.17 M.
The company currently has active open charges totaling ₹49.12 Cr. The company has closed loans amounting to ₹64.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Goel, Leela Goel, Raghav Goel, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899DL1994PLC063407
- Company No.
063407
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Dec 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Medi Plus (India) Limited offer?
Medi Plus (India) Limited offers a wide range of products and services, including Surgical & ICU Equipments, Patient Monitoring System, Medical Equipment & Accessories, Disposable Cannulas, IV Cannula, Three Way Stop Cock.
Who are the key members and board of directors at Medi Plus (India)?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Goel ![]() | Whole-Time Director | 25-Jul-2008 | Current |
Leela Goel ![]() | Whole-Time Director | 31-Jul-2008 | Current |
Raghav Goel ![]() | Director | 01-Sep-2014 | Current |
Alka Goel ![]() | Whole-Time Director | 01-Dec-2015 | Current |
Sunder Goel ![]() | Whole-Time Director | 31-Oct-1995 | Current |
Financial Performance of Medi Plus (India).
Medi Plus (India) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.06% increase. The company also saw a substantial improvement in profitability, with a 21% increase in profit. The company's net worth Soared by an impressive increase of 10.41%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Plus (India)?
In 2022, Medi Plus (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹49.12 Cr
₹64.10 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 47.80 Cr
- Axis Bank Limited : 0.79 Cr
- Others : 0.30 Cr
- Hdfc Bank Limited : 0.23 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Jul 2024 | Others | ₹3.00 M | Open |
25 Mar 2022 | Hdfc Bank Limited | ₹0.80 M | Open |
19 Nov 2021 | Hdfc Bank Limited | ₹1.50 M | Open |
10 Nov 2021 | Axis Bank Limited | ₹7.88 M | Open |
22 Dec 2017 | State Bank Of India | ₹47.80 Cr | Open |
How Many Employees Work at Medi Plus (India)?
Medi Plus (India) has a workforce of 842 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Medi Plus (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Plus (India)'s trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.